These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21033014)

  • 21. Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension.
    Shekerdemian LS; Ravn HB; Penny DJ
    Am J Respir Crit Care Med; 2002 Apr; 165(8):1098-102. PubMed ID: 11956051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controversies in the use of inhaled nitric oxide therapy in the newborn.
    Kinsella JP; Abman SH
    Clin Perinatol; 1998 Mar; 25(1):203-17. PubMed ID: 9523083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhaled nitric oxide reduces the need for extracorporeal membrane oxygenation in infants with persistent pulmonary hypertension of the newborn.
    Christou H; Van Marter LJ; Wessel DL; Allred EN; Kane JW; Thompson JE; Stark AR; Kourembanas S
    Crit Care Med; 2000 Nov; 28(11):3722-7. PubMed ID: 11098980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Echocardiographic prediction of neonatal ECMO outcome.
    Gotteiner NL; Harper WR; Gidding SS; Berdusis K; Wiley AM; Reynolds M; Benson DW
    Pediatr Cardiol; 1997; 18(4):270-5. PubMed ID: 9175523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newborn.
    Kinsella JP; Abman SH
    J Pediatr; 1995 Jun; 126(6):853-64. PubMed ID: 7776084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide.
    Kinsella JP; Neish SR; Ivy DD; Shaffer E; Abman SH
    J Pediatr; 1993 Jul; 123(1):103-8. PubMed ID: 8320602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitric oxide in neonatal hypoxemic respiratory failure.
    Muraca MC; Negro S; Sun B; Buonocore G
    J Matern Fetal Neonatal Med; 2012 Apr; 25 Suppl 1():47-50. PubMed ID: 22372677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacologic therapy of persistent pulmonary hypertension of the newborn.
    Weinberger B; Weiss K; Heck DE; Laskin DL; Laskin JD
    Pharmacol Ther; 2001 Jan; 89(1):67-79. PubMed ID: 11316514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fetal stabilization for antenatally diagnosed diaphragmatic hernia.
    Suita S; Taguchi T; Yamanouchi T; Masumoto K; Ogita K; Nakamura M; Nakayama H; Hara T; Tsukimori K; Nakano H; Kanna T; Takahashi S
    J Pediatr Surg; 1999 Nov; 34(11):1652-7. PubMed ID: 10591563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Persistent pulmonary hypertension of newborn. The PFC syndrome].
    Hörnchen H; Merz U; Wicher W; Mühler E
    Z Kinderchir; 1990 Dec; 45(6):336-41. PubMed ID: 2291336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and management of persistent pulmonary hypertension of the newborn.
    Bendapudi P; Rao GG; Greenough A
    Paediatr Respir Rev; 2015 Jun; 16(3):157-61. PubMed ID: 25765845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pulmonary hypertension in pediatric heart surgery].
    Falcone N
    Rev Esp Anestesiol Reanim; 2001 Dec; 48(10):462-4. PubMed ID: 11792301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of nonsteroidal antiinflammatory drugs in meconium and its relation to persistent pulmonary hypertension of the newborn.
    Alano MA; Ngougmna E; Ostrea EM; Konduri GG
    Pediatrics; 2001 Mar; 107(3):519-23. PubMed ID: 11230592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The structural basis of PPHN.
    Geggel RL; Reid LM
    Clin Perinatol; 1984 Oct; 11(3):525-49. PubMed ID: 6386268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Research advances in persistent pulmonary hypertension of the newborn secondary to congenital diaphragmatic hernia].
    Xiao B; Liu M; Xu C
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Sep; 17(9):1013-9. PubMed ID: 26412189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent pulmonary hypertension in the newborn: therapeutic effect of sildenafil.
    Cruz-Blanquel A; Espinosa-Oropeza A; Romo-Hernández G; Carrillo-Alarcón L; Ponce-Monter H; Ortiz MI
    Proc West Pharmacol Soc; 2008; 51():73-7. PubMed ID: 19544683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors affecting the response to inhaled nitric oxide therapy in persistent pulmonary hypertension of the newborn infants.
    Hwang SJ; Lee KH; Hwang JH; Choi CW; Shim JW; Chang YS; Park WS
    Yonsei Med J; 2004 Feb; 45(1):49-55. PubMed ID: 15004868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current and future therapeutic options for persistent pulmonary hypertension in the newborn.
    Rao S; Bartle D; Patole S
    Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):845-62. PubMed ID: 20528642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of sildenafil in the treatment of persistent pulmonary hypertension of the newborn: a review of the literature.
    Iacovidou N; Syggelou A; Fanos V; Xanthos T
    Curr Pharm Des; 2012; 18(21):3034-45. PubMed ID: 22564297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Criteria for extracorporeal membrane oxygenation in a population of infants with persistent pulmonary hypertension of the newborn.
    Beck R; Anderson KD; Pearson GD; Cronin J; Miller MK; Short BL
    J Pediatr Surg; 1986 Apr; 21(4):297-302. PubMed ID: 3084751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.